Learn about genetics of posterior cortical atrophy studies in Dr. Ertekin-Taner's Precision Medicine in Neurodegeneration Lab at Mayo Clinic.

Background The causative genes for over 60% of inherited peripheral neuropathy (IPN) remain unidentified. This study endeavours to enhance the genetic diagnostic rate in IPN cases by conducting ...

—While MRI can detect abnormal atrophy during preclinical Alzheimer’s disease, atrophy assessment should be tailored to the targeted disease stage and intended use. Structural magnetic resonance ...

This study presents valuable findings on the patterned loss of Purkinje cells in the mouse cerebellum during aging. Convincing evidence shows that Purkinje cell loss with aging occurs in a pattern of ...

Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development. New ...

Multiple sclerosis (MS) affects an estimated 2.3 million people worldwide. Approximately 80% of people with MS have inflammation in the cerebellum, the part of the brain that helps control movement ...

Globally, 23.7% of older adults have mild cognitive impairment (MCI). Proper health strategies are necessary to diagnose and treat people who have MCI, according to a new report. MCI is an early stage ...

Background: Intracranial atherosclerotic disease (ICAD), a common cause of stroke, is associated with cerebral atrophy and cognitive impairment, but the underlying pathophysiology remains unknown. We ...

Researchers have shown that, just like declarative memories, short-term and long-term memories for motor skills form in different regions of the brain, with the cerebellum being critical for the ...

New research reveals that air pollution, especially PM2.5, may contribute to cerebral atrophy but does not seem to impair cognitive function. Urbanization affects the strength of this link. Study: ...